ALFA Filings
Every announcement, straight from the exchange
Every Torrent Pharmaceuticals debt & borrowing announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements
Torrent Pharmaceuticals filed its security cover certificate as on 30-Sep-26 for listed NCDs, showing 141% market-value cover. Secured debt covered by the certificate stands at Rs 11,578.42 Crore.
Torrent Pharmaceuticals filed a security cover certificate for its non-convertible debentures. The certificate confirms a standalone security cover of 0.33 times book value.
Torrent Pharmaceuticals is valuing key brands at Rs. 16,374.09 Crore to raise funds via NCDs. The valuation includes brands like Nexpro, Chymoral, Rozucor, and Veloz.
Torrent Pharmaceuticals Limited filed its security cover certificate for outstanding NCDs totaling ₹11,156.14 Crore. The filing confirms adequate asset coverage as of March 2026.
Torrent Pharmaceuticals Limited submitted details of four listed Non-Convertible Debentures (NCDs) totalling ₹11,000 Crore issued via private placement. The company also confirmed the redemption of NCDs (ISIN INE685A07082) on December 12, 2025. This filing maintains regulatory compliance regarding debt security disclosures for the half-year ended March 31, 2026.
Torrent Pharmaceuticals Limited confirmed the full utilization of proceeds from its issued Commercial Papers for the quarter ending March 31, 2026. This filing adheres to SEBI Master Circular requirements regarding debt instruments.